Track F: Interventions and Program Implementation Abstract Numbering & Table of Contents
The abstracts have been given reference numbers as follows:
- MoOrA1001
- TuPpB2001
- WePeC3001
- ThOr245
- LbOr17
Mo = Monday, Tu = Tuesday, We = Wednesday, Th = Thursday, Lb = Late-Breaker
Or = Oral Abstract Presentation
Pp = Poster Presentation
Pe = Poster Exhibition
Print only abstracts.
The 2,807 printed only abstracts are identified by their special numbering, which begins with a letter A-G (signifying the track) and is followed by a 5 digit number.
Tracks
Track A: Basic Sciences
This track will highlight all aspects related to HIV structure and
replication and its regulation as well as host immune responses.
Drug discovery, research on vaccines and development of animal
models will also be addressed. This track will be of particular
interest to laboratory researchers and clinicians involved in basic
principles of HIV.
Track B: Clinical Sciences and Care
This track will highlight the characteristics and clinical course of
HIV infection and related diseases, the evaluation of diagnostic and
therapeutic tools, including resistance tests, and the clinical trials
and cohort studies which provide the scientific basis for
therapeutic interventions and care. This track will be of particular
interest to investigators and clinicians participating in clinical
research related to HIV-1 infection.
Track C: Epidemiology
This track will highlight the description and dynamics of the
evolving HIV/AIDS epidemic, the natural history and the burden
and impact of HIV infection in the world. Presentations in this
track will be based on both observational and experimental studies,
as well as on surveillance methods. This track will be of particular
interest to public health professionals, academic researchers in
epidemiology or related areas, and people using epidemiologic
parameters in support of HIV/AIDS programs and policies.
Track D: Prevention Science
This track will highlight the design, testing and evaluation of HIV
preventive interventions for both HIV- and HIV+ persons,
including those interventions addressing early diagnosis, co-factors,
and risk and harm reduction. This track will also address
methodological and ethical issues in HIV prevention research. This
track will be of particular interest to those involved in advancing
multidisciplinary (biomedical, behavioral, and social sciences)
investigations of HIV prevention.
Track E: Social Sciences
This track will highlight the scientific investigation of behavioral,
social, economic, political and cultural mechanisms underlying risk
of, and protection from, HIV infection and AIDS, access to and
continuity of care and treatment, and will assess the psychological
and social impact of the epidemic on individuals, communities and
society as a whole. This track will be of particular interest to people
concerned with the social and economic dimensions of the
epidemic who are using concepts, approaches, and frameworks
derived from the well-established body of knowledge of social
sciences and the methodological tools of scientific research.
Interventions, Program Implementation and Policy
Tracks in the Interventions, Program Implementation and Policy
component (Tracks F and G) will present, discuss, and share
lessons learned about programs, activities, and policies related to
HIV/AIDS prevention, care, treatment, support, and impact
mitigation. Component key aims are to improve understanding of
factors contributing to successful and unsuccessful outcomes, to
identify approaches to overcome barriers to implementing,
sustaining, and scaling up effective responses to HIV/AIDS, and to
develop and strengthen effective strategies for action.
Track F: Interventions and Program Implementation
This track will highlight planning, implementation, monitoring and
evaluation of activities/programs for HIV/AIDS prevention;
treatment, care and support; and impact mitigation. Sessions will
focus on sharing lessons learned.
Track G: Advocacy and Policy
This track will highlight description, analysis and lessons learned in
HIV/AIDS-related advocacy and policy. The track will address
both HIV/AIDS specific advocacy and policy, and related areas
such as gender, human rights, economic development, and trade
and patents.
|